New York

Epidemiological Brief

New York City presents a LOW epidemic risk score (17.2), with influenza, pertussis, and COVID-19 as the primary active components. Influenza ILI% of 7.8% (New York and New Jersey combined) indicates residual late-season activity. Pertussis incidence of 1.4 per 100,000 reflects active community transmission in the metro area. COVID-19 incidence of 0.5 per 100,000 adds a modest burden, while measles (0.08 per 100,000) and mpox (0.06 per 100,000) remain low. MetLife Stadium, as one of the tournament's marquee venues, will receive the largest international crowd volumes, elevating importation and secondary spread risk despite the low baseline score. NYCDOHMH and NJDOH should maintain heightened surveillance linkages with venue health posts. Rapid influenza diagnostics, antiviral access, and mpox clinical awareness training for on-site medical teams are recommended. Pre-tournament MMR campaign messaging targeted at communities with documented vaccine hesitancy should be amplified. Dengue risk is low, with a 5.5 adj score reflecting the northeastern climate's limited vector capacity.

Model v2.1.0 · Updated June 11, 2026